# CONMED to acquire Biorez for up to $250M

CONMED Corporation has announced a definitive agreement to acquire privately held Biorez, Inc. for $85 million at closing, plus up to $165 million in earnout payments. The transaction is expected to close in early August 2022.

- Type: Acquisition
- Announced: 2022-08-01
- Where: United States
- Value: $85.0M
- Status: announced
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CONMED Corporation](https://endata.com/companies/36116.md) (acquirer)
- [Biorez](https://endata.com/companies/37833.md) (target)

## Sources

- [lw.com](https://www.lw.com/en/news/2022/08/latham-watkins-represents-biorez-inc-in-definitive-agreement-to-be-acquired-by-conmed), 2022-08-01: "CONMED Corporation (NYSE: CNMD), a medical device company, has announced a definitive agreement to acquire privately held Biorez, Inc., a medical device start-up, on a cash-free, debt-free basis, for cash consideration of US$85 million at closing."
- [conmed.gcs-web.com](https://conmed.gcs-web.com/news-releases/news-release-details/conmed-announces-definitive-agreement-acquire-biorez-inc), 2022-08-01: "The addition of Biorez and its BioBrace platform represents an important step forward for our sports medicine portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.